Steven J. Mento
2016
In 2016, Steven J. Mento earned a total compensation of $1.1M as President and Chief Executive Officer at Conatus Pharmaceuticals, a 30% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $314,875 |
---|---|
Option Awards | $295,289 |
Salary | $503,800 |
Other | $16,650 |
Total | $1,130,614 |
Mento received $503.8K in salary, accounting for 45% of the total pay in 2016.
Mento also received $314.9K in non-equity incentive plan, $295.3K in option awards and $16.7K in other compensation.
Rankings
In 2016, Steven J. Mento's compensation ranked 7,647th out of 14,075 executives tracked by ExecPay. In other words, Mento earned more than 45.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,647 out of 14,075 | 46th |
Division Manufacturing | 2,899 out of 5,489 | 47th |
Major group Chemicals And Allied Products | 954 out of 1,895 | 50th |
Industry group Drugs | 739 out of 1,538 | 52nd |
Industry Pharmaceutical Preparations | 589 out of 1,176 | 50th |
Source: SEC filing on April 27, 2018.
Mento's colleagues
We found one more compensation record of an executive who worked with Steven J. Mento at Conatus Pharmaceuticals in 2016.
2016
David Hagerty
Conatus Pharmaceuticals